We are live on ! Find out more
WST icon

West Pharmaceutical

355 hedge funds and large institutions have $6.76B invested in West Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 132 increasing their positions, 102 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

29% more repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 102

4% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 51

0% more funds holding

Funds holding: 355355 (0)

0.06% less ownership

Funds ownership: 94.09%94.03% (-0.06%)

21% less capital invested

Capital invested by funds: $8.52B → $6.76B (-$1.75B)

71% less call options, than puts

Call options by funds: $2.39M | Put options by funds: $8.11M

Holders
355
Holders Change
Holders Change %
0%
% of All Funds
7.91%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
53
Increased
132
Reduced
102
Closed
51
Calls
$2.39M
Puts
$8.11M
Net Calls
-$5.72M
Net Calls Change
+$6.33M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
51
AMI Asset Management
California
$21M -$674K -6,208 -3%
Public Employees Retirement Association of Colorado
52
Public Employees Retirement Association of Colorado
Colorado
$20.1M -$2.52M -23,231 -10%
Deutsche Bank
53
Deutsche Bank
Germany
$17.4M +$7.78M +71,672 +68%
Thrivent Financial for Lutherans
54
Thrivent Financial for Lutherans
Minnesota
$15.8M +$1.72M +15,857 +11%
RSCM
55
Rock Springs Capital Management
Maryland
$15.7M
Millennium Management
56
Millennium Management
New York
$14.9M +$10.1M +93,221 +159%
AIG
57
American International Group
New York
$14.8M +$163K +1,498 +1%
William Blair & Company
58
William Blair & Company
Illinois
$14.5M -$2.05M -18,861 -11%
New York State Common Retirement Fund
59
New York State Common Retirement Fund
New York
$14M -$331K -3,050 -2%
Renaissance Technologies
60
Renaissance Technologies
New York
$13.7M -$2.26M -20,800 -13%
California Public Employees Retirement System
61
California Public Employees Retirement System
California
$13M -$1.02M -9,395 -7%
Lord, Abbett & Co
62
Lord, Abbett & Co
New Jersey
$13M +$14.4M +132,500 New
PPA
63
Parametric Portfolio Associates
Washington
$12.8M +$550K +5,071 +4%
Adage Capital Partners
64
Adage Capital Partners
Massachusetts
$12.7M -$2.17M -20,000 -13%
Swiss National Bank
65
Swiss National Bank
Switzerland
$12.7M +$109K +1,000 +0.8%
Kayne Anderson Rudnick Investment Management
66
Kayne Anderson Rudnick Investment Management
California
$12.6M +$2.87M +26,425 +26%
Envestnet Asset Management
67
Envestnet Asset Management
Illinois
$12.3M +$13.6M +125,601 New
Manulife (Manufacturers Life Insurance)
68
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$12.2M +$310K +2,859 +2%
SCP
69
Sandhill Capital Partners
New York
$12M +$309K +2,850 +2%
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$11.5M -$8.57K -79 -0.1%
TCIM
71
TIAA CREF Investment Management
New York
$11.1M +$410K +3,776 +3%
O
72
OppenheimerFunds
New York
$10.9M +$11.5M +105,823 +2,003%
TD Asset Management
73
TD Asset Management
Ontario, Canada
$10.8M -$592K -5,460 -5%
Macquarie Group
74
Macquarie Group
Australia
$10.8M +$339K +3,124 +3%
SEI Investments
75
SEI Investments
Pennsylvania
$10.6M +$473K +4,358 +5%

WST Hedge Fund Activity: Q4 2018 in Review

355 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2018, worth a combined $6.76B — down 21% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new WST positions and 51 closed out — a net gain of 2 holders — while 132 added to existing stakes and 102 trimmed.

The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $97.8M. The largest seller was William Blair Investment Management, cutting an estimated $74.3M.

  • 355 institutional investors held West Pharmaceutical (WST) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $6.76B of West Pharmaceutical stock for Q4 2018, down 21% quarter-over-quarter.
  • 53 funds opened new West Pharmaceutical positions in Q4 2018 and 51 closed out, a net change of +2 holders.
  • The largest West Pharmaceutical buyer in Q4 2018 was Capital Research Global Investors, an estimated $97.8M added.
  • The largest West Pharmaceutical seller in Q4 2018 was William Blair Investment Management, an estimated $74.3M sold.

Based on aggregated 13F filings for Q4 2018.